1. Home
  2. LITB vs CGTX Comparison

LITB vs CGTX Comparison

Compare LITB & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LightInTheBox Holding Co. Ltd.

LITB

LightInTheBox Holding Co. Ltd.

N/A

Current Price

$2.80

Market Cap

58.2M

ML Signal

N/A

CGTX

Cognition Therapeutics Inc.

BUY

Current Price

$0.72

Market Cap

79.6M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
LITB
CGTX
Founded
2007
2007
Country
Singapore
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.2M
79.6M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
LITB
CGTX
Price
$2.80
$0.72
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $3.33
AVG Volume (30 Days)
3.9K
★ 470.4K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 62.79
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.36
N/A
Revenue Next Year
$3.80
N/A
P/E Ratio
$10.96
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.63
$0.55
52 Week High
$4.17
$1.93

Technical Indicators

Market Signals
Indicator
LITB
CGTX
Relative Strength Index (RSI) 41.70 23.38
Support Level $2.41 $0.55
Resistance Level $2.99 $1.18
Average True Range (ATR) 0.16 0.06
MACD -0.01 -0.02
Stochastic Oscillator 0.00 7.18

Price Performance

Historical Comparison
LITB
CGTX

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is a e-commerce company, providing a diverse range of affordable lifestyle products directly to consumers. Its brands include Ador, a women's fashion brand targeting women aged 35-55; the second is a golf apparel brand focusing on female golfers aged 35 and above; the third is a women's light party dress brand for the age group of 30 and above. It offers customers products through websites and mobile applications. The company operates and reviews its performance in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of the provision of logistic services to companies and individual customers.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It aims to develop disease-modifying therapies for patients with these disorders. Its product candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, including beta-amyloid and alpha-synuclein. These protein oligomers have been linked to the progression of degenerative diseases such as Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).

Share on Social Networks: